A Lipid-Peptide Microbicide Inactivates Herpes Simplex Virus
Open Access
- 1 August 2004
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (8) , 3182-3184
- https://doi.org/10.1128/aac.48.8.3182-3184.2004
Abstract
A microbicide combining the lipid-ether 1-0-octyl-sn-glycerol (OG; 3 mM) and peptide D2A21 (9 μM) reduced herpes simplex virus type 1 (HSV-1) and HSV-2 titers by at least 1,000-fold, more than the sum of the inactivations produced by OG and D2A21 alone. OG plus D2A21 reduced HSV-1 and HSV-2 titers by ≥1,000-fold in ≤10 and ≤20 min, respectively, whereas OG and D2A21 used alone produced almost no virus inactivation during these times.Keywords
This publication has 11 references indexed in Scilit:
- Enhanced: The Need for a Global HIV Vaccine EnterpriseScience, 2003
- Target cells in vaginal HIV transmissionMicrobes and Infection, 2003
- Herpes simplex viruses: is a vaccine tenable?Journal of Clinical Investigation, 2002
- Antimicrobial peptides of multicellular organismsNature, 2002
- Evaluation of the Inactivation of Infectious Herpes Simplex Virus by Host-Defense PeptidesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2000
- Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1New England Journal of Medicine, 2000
- Genital herpes—how much of a public-health problem?The Lancet, 1998
- Killing of Chlamydia trachomatis by Novel Antimicrobial Lipids Adapted from Compounds in Human Breast MilkAntimicrobial Agents and Chemotherapy, 1998
- Herpes simplex virus infections of women and their offspring: implications for a developed society.Proceedings of the National Academy of Sciences, 1994
- Inactivation of enveloped viruses and killing of cells by fatty acids and monoglyceridesAntimicrobial Agents and Chemotherapy, 1987